ArticleNPJ digital medicine2026
A domain-adaptive deep contrastive network for magnetic resonance imaging-driven bladder cancer classification.
Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Artificial intelligence and predictive tools in non-muscle invasive bladder cancer: a narrative review of current insights and advances.Translational andrology and urology · 2026Review
- A risk-adapted approach to reTURBT in high-grade T1 NMIBC.Bladder cancer (Amsterdam, Netherlands)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bladder cancer is one of the most prevalent malignancies of the urinary system and is associated with high morbidity and mortality. With advances in medical image analysis, deep learning has shown promise for automated bladder cancer classification using magnetic resonance imaging (MRI). However, clinical deployment remains challenging due to substantial inter-center distributional discrepancies and limited feature discriminability between non-muscle-invasive bladder cancer (NMIBC) and muscle-invasive bladder cancer (MIBC). To address these challenges, we propose a Domain-Adaptive Deep Contrastive Network (DADCNet) for MRI-based bladder cancer classification. The proposed framework jointly incorporates source- and target-domain samples during feature learning to obtain domain-invariant yet discriminative representations, thereby improving cross-center generalization. In addition, a deep contrastive learning strategy is introduced to enhance inter-class separability and intra-class compactness, leading to more robust classification. Experiments conducted on a multi-center bladder cancer MRI dataset demonstrate that DADCNet consistently outperforms existing convolutional neural network- and Transformer-based methods, achieving an accuracy of 0.955, an F1-score of 0.955, and an area under the curve of 0.991.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.